1. |
Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation, 2014, 129(8): 837-847.
|
2. |
Lip GYH, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest, 2012, 142(6): 1489-1498.
|
3. |
Ball J, Carrington MJ, McMurray JJ, et al. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol, 2013, 167(5): 1807-1824.
|
4. |
Guttmann OP, Rahman S, O'Mahony C, et al. Systematic review of atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy. Europ Heart J, 2013, 34(1): 2965.
|
5. |
Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation, 2011, 123(15): 1587.
|
6. |
He W, Chu Y. Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis. Sci Rep, 2017, 7(1): 3360.
|
7. |
Youssef I, Kamran H, Yacoub M, et al. Obstructive sleep apnea as a risk factor for atrial fibrillation: a meta-analysis. J Sleep Disord Ther, 2018, 7(1): 282.
|
8. |
Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ, 2016, 532: h7013.
|
9. |
Wanahita N, Messerli FH, Bangalore S, et al. Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J, 2008, 155(2): 310-315.
|
10. |
Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil, 2010, 17(6): 706-712.
|
11. |
Reddy V, Taha W, Kundumadam S, et al. Atrial fibrillation and hyperthyroidism: a literature review. Indian Heart J, 2017, 69(4): 545-550.
|
12. |
Heeringa J, Hoogendoorn EH, van der Deure WM, et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med, 2008, 168(20): 2219-2224.
|
13. |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
|
14. |
Komatsu R, Karimi N, Zimmerman NM, et al. Biochemically diagnosed hypothyroidism and postoperative complications after cardiac surgery: a retrospective cohort analysis. J Anesth, 2018, 32(5): 663-672.
|
15. |
Jaimes MC, Torrado LAA, Reyes NFS, et al. Hypothyroidism is a risk factor for atrial fibrillation after coronary artery bypass graft. Braz J Cardiovasc Surg, 2017, 32(6): 475-480.
|
16. |
Worku B, Tortolani AJ, Gulkarov I, et al. Preoperative hypothyroidism is a risk factor for postoperative atrial fibrillation in cardiac surgical patients. J Card Surg, 2015, 30(4): 307-312.
|
17. |
Kim EJ, Lyass A, Wang N, et al. Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study). Am Heart J, 2014, 167(1): 123-126.
|
18. |
Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ, 2012, 345: e7895.
|
19. |
Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol, 2018, 14(5): 301-316.
|
20. |
Aoki Y, Belin RM, Clickner R, et al. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid, 2007, 17(12): 1211-1223.
|
21. |
Walsh JP, Bremner AP, Feddema P, et al. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab, 2010, 95(3): 1095-1104.
|
22. |
Jensen MT, Marott JL, Allin KH, et al. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study. Eur J Prev Cardiol, 2012, 19(1): 102-108.
|
23. |
Ladenson PW, Kristensen JD, Ridgway EC, et al. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med, 2010, 362(10): 906-916.
|
24. |
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation, 2019, 140(2): e125-e151.
|
25. |
陈明辉. 甲状腺功能减退对稳定性心绞痛患者发生房颤的影响. 哈尔滨医药, 2015, (3): 177-178, 179.
|